SKYSTAR BIO-PHARMA CO's ticker is SKBI and the CUSIP is 830884300. A total of 10 filers reported holding SKYSTAR BIO-PHARMA CO in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $65,000 | -31.6% | 24,300 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $95,000 | -7.8% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $103,000 | +1.0% | 24,300 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $102,000 | -42.7% | 24,300 | 0.0% | 0.00% | -40.0% |
| Q2 2014 | $178,000 | +11.9% | 24,300 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $159,000 | – | 24,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 147,926 | $141,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 181 | $0 | 0.00% |
| HighTower Advisors, LLC | 22,845 | $22,000 | 0.00% |
| MORGAN STANLEY | 11,593 | $11,000 | 0.00% |
| BlackRock Institutional Trust Company, N.A. | 175,708 | $167,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 15,900 | $15,000 | 0.00% |
| Walleye Trading LLC | 200 | $0 | 0.00% |
| Citadel Advisors | 18,296 | $17,000 | 0.00% |
| Renaissance Technologies | 52,300 | $50,000 | 0.00% |
| UBS Group AG | 3,304 | $3,000 | 0.00% |